 Nigeria, isilu wa kagh Torresבע Mooda tan y疫 Council preetafuza kiviwa kab snakeshtu kiniwae pizad네요, na kwaemu 1,119,000 kere na, Againakun을 bata y kazi kansu akua in Afrika in 2020, akunting for 22.5% of the global burden. There is therefore an urgent need for effective and sustainable interventions to prevent and control cervical cancer in Nigeria and other African countries. Gadaseil is a vaccine that protects against human papilumia virus, HPV, a common sexually transmitted infection that can cause cervical, vaginal, vulva, and other cancers recommended for girls and boys aged 11 to 12 years, but can be given as early as 9 years or as late as 26 years. We are going to continue to have engagement internally with CBN, federal minister of finance, customs, NAQS, and externally with European Union. With European Union we are already getting some results. The EU has reduced the inspection of melon from 100% to 50%. We're not there yet but it's better than 100% all the time. In the interim, I implore all Nigerian exporters trading in NAVDAC regulated products to obtain necessary certifications for processing of their products. The National Primary Health Care Development Agency, NPHCDA, will commence the introduction of the off-label use of quadrivalent Gadaseil vaccine as a single dose shadow into routine immunization in Nigeria in the last quarter of 2023. The decision to deploy the off-label Gadaseil as a single dose shadow is based on the scientific evidence that shows that a single dose of Gadaseil vaccine can provide solid protection against cervical cancer caused by human papilumia virus, HPVs. NAVDAC is in support of this decision as data from immunogenicity trials post hook analysis of every KC trials and post licensure observational studies amongst females have demonstrated that a single dose of HPV vaccine is sufficient to elicit an immune response that provides similar protection as a multi-dose regimen against initial and persistent HPV infection. I am delighted to stand here with the DG of NAVDAC and our partners and donors to share that this vaccine will be provided free of charge to all eligible girls in Nigeria commencing on October 24, 2023. Alongside our partners and donors, we have secured over 6 million doses of the HPV vaccine and essential supplies. We have conducted numerous fora to raise awareness amongst stakeholders including parents and caregivers regarding the pivotal importance of HPV vaccination. To address any concerns or misconceptions, we have engaged with communities and established a robust monitoring and evaluation framework to measure the impact and progress of the vaccination campaign. Thank you for watching.